Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Capital/Financing Update 2024

Mar 25, 2024

61842_rns_2024-03-25_8084d9db-a380-4075-b2df-50c2abbb5e57.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block

27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: [email protected] www.solara.co.in

Keelakottaiyur Village, Melakottaiyur (Post)

March 25, 2024

The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Scrip Code: 541540 Scrip Code: SOLARA

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051

Dear Sirs,

We refer to our letter dated November 14, 2023 wherein we had informed about the proposal for Sale of Land of Building of SeQuent Penems Private Limited, a wholly owned subsidiary of the Company.

Further to the above and in modification to the above proposal, the Board of Directors have today approved sale of 100% shareholding in SeQuent Penems Private Limited.

Requisite disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015 read with SEBI/ HO/ CFD/ CFDPoD-1/ P/ CIR/ 2023/ 123 dated July 13, 2023 will be provided when the transaction is finalised.

We request you to take the same on record.

Thanking you,

Yours faithfully, For Solara Active Pharma Sciences Limited

SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2024.03.25 14:01:08 +05'30' S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942